Delayed-Phase Dynamic CT Enhancement as a Prognostic Factor for Mass-forming Intrahepatic Cholangiocarcinoma
Yoshiki Asayama(Oita University), Hiroshi Honda(Kyushu University), Akihiro Nishie(Kyushu University), Akinobu Taketomi(Hokkaido University), Tsuyoshi Tajima(National Center for Global Health and Medicine), Hiroyuki Irié(Saga University), Tomohiro Nakayama(Kyushu University), Masakazu Hirakawa(Kyushu University Hospital), Kengo Yoshimitsu(Kyushu University), Shin-ichi Aishima(Kyushu University), Daisuke Kakihara(Kyushu University)
Cited by 161
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality
|American Journal of Respiratory and Critical Care Medicine|2019|260
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244